PATENT CLAIM ANALYSIS

Application Number: 15914770
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "006000"]

Abstract:
The invention is a novel MECP2E1 splice variant and its corresponding polypeptide. The invention also includes methods of using these nucleic acid sequences and proteins in medical diagnosis and treatment of neuropsychiatric disorders or development disorders.

Claim (Index 12):
A nucleic acid probe comprising a fragment of MECP2 sequence or the complementary thereof, wherein the MECP2 sequence has the sequence of SEQ ID NO: 1, and comprises an adenine to thymine mutation at nucleotide position corresponding to position 8 of SEQ ID NO: 1, and\n wherein the nucleic acid probe specifically binds under high stringency conditions to the MECP2 sequence, and wherein the nucleic acid probe is detectably labeled.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.22581
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15914800', '12313251', '14100889', '12657559', '11352153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6992503043152737
- 35 USC 102 Novelty (BERT): 0.573636459039905
- Combined Prediction Score: 0.6866889197877368
- Mean Citation Score: 498.36984800000016
- Max Citation Score: 508.83307
- Similarity Product: 401.93012570519807

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test